These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1291598)

  • 1. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
    Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
    J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced thyroid gland dysfunction.
    Mechlis S; Lubin E; Laor J; Margaliot M; Strasberg B
    Am J Cardiol; 1987 Apr; 59(8):833-5. PubMed ID: 3825945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis.
    Kaplan J; Ish-Shalom S
    Am J Med; 1991 Jun; 90(6):750-2. PubMed ID: 2042691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
    Campi I; Perego GB; Ravogli A; Groppelli A; Parati G; Persani L; Fugazzola L
    Eur J Endocrinol; 2019 Nov; 181(5):519-524. PubMed ID: 31536966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
    Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
    Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.
    Cappiello E; Boldorini R; Tosoni A; Piraneo S; Bernasconi R; Raggi U
    J Endocrinol Invest; 1995 Dec; 18(11):862-8. PubMed ID: 8778159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.
    Mariotti S; Loviselli A; Murenu S; Sau F; Valentino L; Mandas A; Vacquer S; Martino E; Balestrieri A; Lai ME
    J Endocrinol Invest; 1999 Jan; 22(1):55-63. PubMed ID: 10090138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
    Roti E; Minelli R; Gardini E; Bianconi L; Gavaruzzi G; Ugolotti G; Neri TM; Braverman LE
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1273-7. PubMed ID: 1331165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone: a common source of iodine-induced thyrotoxicosis.
    Martino E; Aghini-Lombardi F; Mariotti S; Bartalena L; Braverman L; Pinchera A
    Horm Res; 1987; 26(1-4):158-71. PubMed ID: 2885251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.
    Lambert M; Unger J; De Nayer P; Brohet C; Gangji D
    J Endocrinol Invest; 1990 Jun; 13(6):527-30. PubMed ID: 2258582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid hormones and cardiovascular system].
    Límanová Z; Jiskra J
    Vnitr Lek; 2016; 62(9 Suppl 3):92-98. PubMed ID: 27734699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of amiodarone on the thyroid].
    Toni M; Anda E; Pineda J; Martínez de Esteban JP; Ollero MD
    An Sist Sanit Navar; 2009; 32(3):363-70. PubMed ID: 20094097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.